Discontinuation report RISEDRONATE
Report ID | 53377 |
Drug Identification Number | 02352141 |
Brand name | RISEDRONATE |
Common or Proper name | RISEDRONATE |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 35MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-07-06 |
Actual discontinuation date | 2018-07-06 |
Remaining supply date | 2018-07-06 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Sivem Risedronate available under another DIN# |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-07-31 | French | Compare |
v3 | 2018-07-31 | English | Compare |
v2 | 2018-06-29 | French | Compare |
v1 | 2018-06-29 | English | Compare |
Showing 1 to 4 of 4